Jackie Nguyen, MD
Ophthalmology · Portland, MENPI 1326094533
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $710 of the $1,083 with a category attached, or 65.5%. Alcon accounts for 65.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $710 and has fallen 73.9% since, to $185 in 2024.
Across 13 payments — averaging $83.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$710
- Mallinckrodt Hospital Products Inc.$105
- Genentech USA, Inc.$94
- AbbVie$65
- Bausch & Lomb, A Division Of Bausch Health US, LLC$57
- Astellas Pharma US Inc$35
- plus $17 from 1 others
What the payments were for
- Travel & lodging$71066%
- Food & beverage$37334%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 1 | $710 |
| Mallinckrodt Hospital Products Inc. | 1 | $105 |
| Genentech USA, Inc. | 5 | $94 |
| AbbVie | 1 | $65 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $57 |
| Astellas Pharma US Inc | 1 | $35 |
| Novartis | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,083 in reported general payments places this provider in the 70th percentile of 74 ophthalmology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 131 | $5,621 |
| Difluprednate | 22 | $2,238 |
| Brimonidine Tartrate | 47 | $2,067 |
| Latanoprost | 73 | $834 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $529 |
| Ofloxacin | 39 | $358 |
| Dorzolamide Hcl | 29 | $296 |
| Timolol Maleate | 40 | $269 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Portland
- Charles ZacksPortland$36K
- Hallie HahnPortland$5K
- Samuel SolishPortland$4K
- Ravindra ShahPortland$4K
- Richard FrancePortland$4K
- Tamzid RahmanPortland$3K
- Margaret PollardPortland$1K
- Adam SisePortland$1K
- John LippincottPortland$994
- Benjamin FowlerPortland$763
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.